TY  - JOUR
AU  - Ceperuelo-Mallafre, Victoria
AU  - Reverte, Laia
AU  - Peraire, Joaquim
AU  - Madeira, Ana
AU  - Maymo-Masip, Elsa
AU  - Lopez-Dupla, Miguel
AU  - Gutierrez-Valencia, Alicia
AU  - Ruiz-Mateos, Ezequiel
AU  - Buzon, Maria Jose
AU  - Jorba, Rosa
AU  - Vendrell, Joan
AU  - Auguet, Teresa
AU  - Olona, Montserrat
AU  - Vidal, Francesc
AU  - Rull, Anna
AU  - Fernandez-Veledo, Sonia
PY  - 2022
DO  - 10.3389/fimmu.2022.912579
UR  - http://hdl.handle.net/10668/20589
T2  - Frontiers in immunology
AB  - Coronavirus-19 (COVID-19) disease is driven by an unchecked immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus which alters host mitochondrial-associated mechanisms. Compromised mitochondrial health results in...
LA  - en
PB  - Frontiers Research Foundation
KW  - COVID-19
KW  - energy-related metabolites
KW  - fluorometric quantification
KW  - pyruvate
KW  - semi-targeted metebolomics
KW  - Biomarkers
KW  - C-Reactive Protein
KW  - COVID-19
KW  - Creatinine
KW  - Glucose
KW  - Humans
KW  - Ketoglutaric Acids
KW  - Lactates
KW  - Prognosis
KW  - Pyruvic Acid
KW  - SARS-CoV-2
KW  - Succinates
KW  - Tricarboxylic Acids
TI  - Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes.
TY  - research article
VL  - 13
ER  -